EVALUATION OF THE CLL-IPI IN PREVIOUSLY UNTREATED CLL PATIENTS RECEIVING CHEMO-IMMUNOTHERAPY AS FIRST-LINE TREATMENT: ANALYSIS OF 845 CASES.

EHA Library, Massimo GENTILE, 215410

SPONTANEOUS CLINICAL REGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGIC FEATURES OF 27 NEW CASES FROM THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) INTERNATIONAL REGISTRY

EHA Library, Ilaria Del Giudice, 215411

A PROGNOSTIC TOOL FOR THE IDENTIFICATION OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AT IMMINENT RISK OF PROGRESSION

EHA Library, Lodovico Terzi di Bergamo, 215412

SURVIVAL CONTINUES TO INCREASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED ANALYSIS AMONG 19,131 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2015

EHA Library, Lina van der Straten, 215413

PROGNOSTICATION AND FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED ANALYSIS AMONG 1,677 PATIENTS DIAGNOSED IN THE NETHERLANDS

EHA Library, Lina van der Straten, 215414

“IMMUNO-FLOW-FISH”: HIGH THROUGHPUT FLUORESCENCE IN SITU HYBRIDISATION OF PHENOTYPED CHRONIC LYMPHOCYTIC LEUKAEMIA BY IMAGING FLOW CYTOMETRY FOR CLINICAL APPLICATION

EHA Library, Wendy Erber, 215415

EXPRESSION OF ANTIGENS INVOLVED IN THE FORMATION OF AN IMMUNOLOGICAL SYNAPSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Yulia Davydova, 215416

IDENTIFICATION OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT HIGH RISK OF INFECTION OR TREATMENT THROUGH MACHINE LEARNING ALGORITHMS

EHA Library, Carsten Niemann, 215417

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN RELATION TO RESPONSE TO FIRSTLINE THERAPY AND SUBSEQUENT TREATMENTS – A METAANALYSIS OF HRQOL MEASURED IN PHASE III TRIALS OF THE GERMAN CLL STUDY GROUP

EHA Library, Nadine Kutsch, 215418

T-LARGE GRANULAR LYMPHOCYTIC (T-LGL) LEUKEMIA: A LONG-TERM STUDY ON 51 PATIENTS-COULD WE CONFINE THE USE OF THE TERM “LEUKEMIA”?

EHA Library, Xanthi Yiakoumis, 215419

FLOW CYTOMETRY AND PCR-BASED T-CELL CLONALITY TESTING FOR DISCRIMINATING BETWEEN REACTIVE AND NEOPLASTIC PROLIFERATION OF LARGE GRANULAR LYMPHOCYTES

EHA Library, Natalia Chernova, 215420

A US BASED SURVEY: THE EXPERIENCES AND PERSPECTIVES OF 1147 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Brian Koffman, 215421

CHRONIC LYMPHOCYTIC LEUKEMIA IN ICELAND: A NATION-WIDE EPIDEMIOLOGY STUDY FROM 2003 TO 2016

EHA Library, Hrafn Thorvaldsson, 215422

ENRICHMENT OF ASXL1 PATHOGENIC VARIANTS AMONG PRIMARY REFRACTORY CML PATIENTS

EHA Library, Kristin Gustafsson, 215423

THE PIVOTAL ROLE OF INSULIN-LIKE GROWTH FACTOR PATHWAY AS A THERAPEUTIC TARGET IN ABL TYROSINE KINASE INHIBITOR RESISTANT LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 215424

ASXL1 MUTATIONS ARE FREQUENT IN CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO TYROSINE KINASE INHIBITORS BUT NOT IN PATIENTS WITH OPTIMAL RESPONSE

EHA Library, Marcin Machnicki, 215425

THE UNCOVERING OF A BCR-ABL1 TYROSINE KINASE-INDEPENDENT SIGNATURE REVEALS NEW POTENTIAL THERAPEUTIC TARGETS IN CHRONIC MYELOID LEUKAEMIA STEM CELLS

EHA Library, Mhairi Copland, 215426

OPTIMAL TIME POINT FOR BCR-ABL1 KD MUTATION ANALYSIS IN CML PATIENTS; BASED ON 2013 ELN GUIDELINE

EHA Library, Young Rok Do, 215427

CLONAL SELECTION DETERMINES RESULTANT DOMINANCE OF TYROSINE KINASE INHIBITOR-RESISTANT CELLS IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Benjamin Leow, 215428

WT1 ANALYSIS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

EHA Library, Sabrina COLUZZI, 215429

DIGITAL DROPLET PCR MAY BETTER IDENTIFY CANDIDATES FOR TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA REGARDLESS OF MEDIAN TREATMENT DURATION

EHA Library, Gioia colafigli, 215430

FREQUENCY OF TYPICAL AND ATYPICAL FUSION TRANSCRIPTS IN PATIENTS WITH BCR-ABL1-POSITIVE LEUKEMIAS – A SINGLE INSTITUTION STUDY

EHA Library, Gueorgui Balatzenko, 215431

PATIENT-SPECIFIC BCR-ABL1 GENOMIC FUSION ANALYSIS OF MINIMAL RESIDUAL DISEASE OF CML PATIENTS ELIGIBLE FOR TKI STOPPING SIGNIFICANTLY OUTPERFORMED MRNA DETECTION EITHER BY QPCR OR DIGITAL PCR

EHA Library, Katerina Machova, 215432

TREATMENT-FREE REMISSION AFTER SECOND-STOP OF IMATINIB THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Sukjoong Oh, 215433

TWO YEARS OF THERAPY WITH MATINIB GENERICS IN CHRONIC MYELOID LEUKEMIA; A REPORT FROM THE POLISH ADULT LEUKEMIA GROUP (PALG) IMATINIB GENERICS REGISTRY

EHA Library, Tomasz Sacha, 215434

MAINTENANCE THERAPY WITH DASATINIB ADMINISTRATED EVERY OTHER DAY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Clemence Loiseau, 215435

PONATINIB 15 MG DAILY, COMBINING EFFICACY AND TOLERABILITY. A RETROSPECTIVE SURVEY IN ITALY.

EHA Library, gianni binotto, 215436

THE EUTOS LONG-TERM SURVIVAL SCORE PREDICTS RESPONSE AND SURVIVAL OF ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS BETTER THAN SOKAL SCORE

EHA Library, Fausto Castagnetti, 215437

CARDIOVASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH SECOND-GENERATION TYROSINE KINASE INHIBITORS IN REAL-LIFE PRACTICE. IDENTIFICATION OF RISK FACTORS AND ROLE OF PROPHYLAXIS

EHA Library, Giovanni Caocci, 215438

ULTRA-SENSITIVE DETECTION OF TYROSINE KINASE INHIBITOR RESISTANT MUTATIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS USING MISEQ ILLUMINA NEXT GENERATION SEQUENCING PLATFORM

EHA Library, Marianna Romžová, 215439

PEG-INTERFERON ΑLPHA 2B CAN IMPROVE MOLECULAR RECURRENCES IN THE TREATMENT-FREE REMISSION; A PILOT STUDY WITH 18-MONTH FOLLOW-UP

EHA Library, Manuel Ayala, 215440

CROSS-INTOLERANCE WITH BOSUTINIB AFTER PRIOR TYROSINE KINASE INHIBITORS IN PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE LEUKEMIA: PHASE 1/2 STUDY UPDATE

EHA Library, Jorge Cortes, 215441

CHRONIC MYELOID LEUKEMIA ITALIAN MULTICENTER OBSERVATIONAL STUDY (CML-IT-MOS): ANALYSIS OF CLINICAL CHARACTERISTICS OF 1330 CML PATIENTS TREATED IN REAL-LIFE IN 66 ITALIAN CENTERS OF THE GIMEMA GROUP

EHA Library, Giorgina Specchia, 215442

IMATINIB STOP STUDY FEASIBLE TO JAPANESE CLINICAL SETTING.

EHA Library, Kensuke Usuki, 215443

THE TARGET UK STUDY: AN EVALUATION OF TYROSINE KINASE INHIBITOR RESPONSE MONITORING PATTERNS AND REAL-WORLD MOLECULAR RESPONSE RATES IN UK PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Adam Mead, 215444

THE OCCURRENCE AND SURVIVAL OF COLD AGGLUTININ DISEASE IN DENMARK

EHA Library, Sigbjørn Berentsen, 215445

DENSITY, HETEROGENEITY AND DEFORMABILITY OF RED CELLS AS MARKERS OF CLINICAL SEVERITY IN HEREDITARY SPHEROCYTOSIS

EHA Library, Richard van Wijk, 215446

LONG-TERM TREATMENT RESPONSE BASED ON SEVERITY OF GAUCHER DISEASE TYPE 1 AT BASELINE IN TREATMENT-NAÏVE ADULT PATIENTS AFTER 8 YEARS OF TREATMENT WITH ORAL ELIGLUSTAT

EHA Library, Elena Lukina, 215448

COMBINED EMA-BINDING TEST AND OSMOTIC GRADIANT EKTACYTOMETRY SIGNIFICANTLY IMPROVE THE LABORATORY DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS

EHA Library, Andreas Glenthøj, 215449

PREVALENCE AND PREDICTORS OF LIVER FIBROSIS EVALUATED BY VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (FIBROSCAN®) IN ADULT PATIENTS WITH TYPE 1 GAUCHER DISEASE

EHA Library, Maria Domenica Cappellini, 215450

PREVALENCE AND CLINICAL SIGNIFICANCE OF SMALL PNH CLONES IN PATIENTS WITH PRIMARY AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Bruno Fattizzo, 215451

COMBINATION TREATMENT OF RITUXIMAB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOR WARM AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Caroline Piatek, 215452

THE ESTABLISHMENT OF SD RAT MODEL AND HISTOPATHOLOGICAL STUDY OF IMMUNE HEMOLYTIC DISEASE INDUCED BY ANTIBODY.

EHA Library, sai yan, 215453

ALPS AND GAUCHER DISEASE. A CLINICAL AND IMMUNOLOGICAL OVERLAP

EHA Library, Maurizio Miano, 215454

ORGAN INVOLVEMENT IN RARE HEREDITARY HEMOLYTIC ANEMIA

EHA Library, Stephanie van Straaten, 215455

SUCCESSFUL TREATMENT OF MEGALOBLASTIC ANEMIA WITH BONE MARROW MYELODYSPLASIA IN LESCH-NYHAN SYNDROME

EHA Library, Maciej Machaczka, 215456

CORD BLOOD DERIVED GAMMA-DELTA T CELLS CAN BE EXPONENTIALLY EXPANDED IN VITRO TO INDUCE POTENT CYTOTOXICITY AGAINST HUMAN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Alice Cheung, 215457

SYNERGISTIC ANTITUMORAL EFFICACY OF A NOVEL REPLICATIVE ADENOVIRUS SG611-PDCD5 AND DAUNORUBICIN IN HUMAN LEUKEMIC CELLS

EHA Library, Ya-Lan Zhou, 215458

NOVEL RNA CONSTRUCT INCREASES PERFORIN AND GRANZYME B IN NATURAL KILLER AND CYTOTOXIC T CELLS

EHA Library, Arnika Wagner, 215459

THE REDUCTION OF GRAFT-VERSUS-HOST DISEASE AND TRANSFUSIONAL NEEDS AFTER THE APPLICATION OF MESENCHYMAL STEM CELL THERAPY FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hajnalka Andrikovics, 215460

IMMUNOGENICITY OF TISAGENLECLEUCEL IN RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) AND DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS

EHA Library, Theodore Laetsch, 215461

CONSIDERATIONS FOR TISAGENLECLEUCEL DOSING RATIONALE

EHA Library, Rakesh Awasthi, 215462

MTL-CEBPA, A SMALL ACTIVATING RNA FOR INTRAVENOUS ADMINISTRATION TO ENHANCE C/EBPΑ EXPRESSION IN PATIENTS WITH LIVER CANCER SHOWS POTENTIAL USE IN NEUTROPENIA

EHA Library, Choon Tan, 215463

SIGNIFICANT ARI-0001 (A3B1:CD8:4-1BB:CD3Z CAR19) CELL EXPANSION IN A PATIENT WITH REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PRE-LYMPHOAPHERESIS IBRUTINIB ADMINISTRATION.

EHA Library, Valentín Ortiz-Maldonado, 215464

HIGH BASELINE FERRITIN IS ASSOCIATED WITH GRADE 2 CRS REQUIRING TOCILIZUMAB OR GRADE ≥ 3 CRS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH BB2121 ANTI-BCMA CAR T CELLS

EHA Library, Jesus Berdeja, 215465

THE COMBINATION OF CD19/BCMA-DIRECTED CART CELLS INDUCED THERAPEUTIC RESPONSE AND REVERSIBLE COMPARTMENTAL CYTOKINE RELEASE SYNDROME CONFINED TO CEREBRAL REGION IN A PATIENT WITH CNS MULTIPLE MYELOMA

EHA Library, Caixia Li, 215466

INITIAL EXPERIENCE IN US COMMERCIAL MANUFACTURING OF TISAGENLECLEUCEL, A CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR PEDIATRIC RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Brian Majors, 215467

ALLOGENEIC NK CELLS AND THEIR USE IN CLINICAL TRIALS

EHA Library, Ludovit Bielik, 215468

IMMUNO-T, A MOTION COMIC EDUCATING PATIENTS AND CAREGIVERS ON HOW IMMUNOTHERAPY WORKS.

EHA Library, Tessa Kerre, 215469

PERTURBATION OF FETAL LIVER STROMAL CELL FUNCTION BY TRISOMY 21 PROMOTES INCREASED ERYTHRO-MEGAKARYOPOIESIS BY FETAL HSPC

EHA Library, Natalina Elliott, 215470

PROTEIN KINASE CK2 AS A NEW PLAYER IN GATA-1 REGULATION DURING ERYTHROPOIESIS

EHA Library, Laura Quotti Tubi, 215471

TRANSCRIPTION FACTORS REGULATE DNA METHYLATION DYNAMICS IN HEMATOPOIETIC DEVELOPMENT

EHA Library, Takahiro Suzuki, 215472

CANONICAL NOTCH SIGNALING IS DISPENSIBLE FOR ADULT STEADY-STATE AND STRESS MYELO-ERYTHROPOIESIS

EHA Library, Sara Duarte, 215473

ENHANCING BONE MARROW TREPHINE BIOPSY ANALYZES: DEFINING PEDIATRIC LYMPHOID SUBPOPULATION REFEERENCE RANGES BY AUTOMATED ENUMERATION

EHA Library, Jacques Malherbe, 215474

ROLE OF SPHINGOLIPID SIGNALING IN HEMATOPOIETIC STEM AND PROGENITOR CELL MOBILIZATION

EHA Library, Alexander Carpinteiro, 215475

TELOMERASE TRANSCRIPTS FLOATING IN CANCER-DERIVED EXOSOMES REPROGRAM THE MICRORNA TRANSCRIPTOME PROFILE OF THE RECIPIENT CELLS

EHA Library, Daniela Likonen, 215476

ALTERATIONS IN STROMAL PRECURSOR CELLS IN THE BONE MARROW OF PATIENTS WITH LEUKEMIA IN THE ONSET OF THE DISEASE AND AFTER TREATMENT

EHA Library, Nataliya Petinati, 215477

LYMPHOPENIA AND RISK OF INFECTIONS AND INFECTION-RELATED DEATH IN DENMARK, 2003-2013: A PROSPECTIVE COHORT STUDY OF 98,344 INDIVIDUALS FROM THE GENERAL POPULATION

EHA Library, Marie Warny, 215478

HEMATOPOIETIC EFFECTS OF A COMPOUND: SXN AGAINST MYELOSUPPRESSION

EHA Library, Fuling Zhou, 215479

IMPACT OF SPLENECTOMY ON CD34+ BLOOD COUNT

EHA Library, Irina Galtseva, 215480

VERY LATE RELAPSES (VLRS) IN HODGKIN LYMPHOMA (HL) OCCURING ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY ± RADIOTHERAPY (CT±RT): PATTERN OF RISK OVER 35 YEARS AND THE SIGNIFICANCE OF HISTOLOGY

EHA Library, Theodoros Vassilakopoulos, 215481

BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE III OR IV HODGKIN LYMPHOMA: IMPACT OF CYCLE 2 PET RESULT ON MODIFIED PROGRESSION-FREE SURVIVAL

EHA Library, Robert Chen, 215482

BENDAMUSTINE IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA AFTER FAILURE OR SUBOPTIMAL RESPONSES TO NIVOLUMAB THERAPY.

EHA Library, Lepik Kirill, 215483

NIVOLUMAB RESTORES SENSITIVITY TO CHEMOTHERAPY IN CHEMOREFRACTORY CLASSICAL HODGKIN LYMPHOMA PATIENTS

EHA Library, Carmelo Carlo-Stella, 215484

EARLY DETECTION OF RECURRENCE IN HIGH-RISK HODGKIN LYMPHOMA IN FIRST COMPLETE REMISSION IMPROVES OUTCOME

EHA Library, Novella Pugliese, 215485

THE RISK OF LUNG CANCER IN HODGKIN LYMPHOMA SURVIVORS; A US POPULATION-BASED STUDY.

EHA Library, Mohamed Moussa, 215486

PROGNOSTIC VALUE OF FDG-PET QUANTITATIVE ASSESSMENT OF TUMOR REDUCTION BY ΔSUVMAX, ΔTMTV AND ΔTLG IN HODGKIN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS HEMATOPOIEIC STEM CELL TRANSPLANTATION

EHA Library, Pilar Perlaza, 215487

DIFFERENTIAL DIAGNOSIS OF ENLARGED LYMPH NODE USING ULTRASOUND ELASTOSONOGRAPHY

EHA Library, Novella Pugliese, 215488

FRONTLINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY EXHIBITS SUPERIOR MODIFIED PROGRESSION-FREE SURVIVAL VS CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE III OR IV HODGKIN LYMPHOMA: PHASE 3 ECHELON-1 STUDY

EHA Library, Andrea Gallamini, 215489

EARLY INTERIM POSITRON EMISSION TOMOGRAPHY (PET) EVALUATION OF RESPONSE AFTER 2 ABVD CYCLES IN ADVANCED HODGIN LYMPHOMA (HL): 8-YEAR EXPERIENCE IN HELLENIC DEPARTMENTS – CONCLUSIONS AND LIMITATIONS

EHA Library, Theodoros Vassilakopoulos, 215490

THE IMPACT OF CXCR4 MUTATION SUBTYPES IN THE RESPONSE AND PROGRESSION-FREE SURVIVAL OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

EHA Library, Jorge Castillo, 215491

IBRUTINIB SHOWS PROLONGED PROGRESSION-FREE SURVIVAL IN SYMPTOMATIC, PREVIOUSLY TREATED PATIENTS WITH MYD88 MUTATED WALDENSTROM'S MACROGLOBULINEMIA: LONG-TERM FOLLOW-UP OF PIVOTAL TRIAL (NCT01614821).

EHA Library, Steven Treon, 215492

IMPROVED DEPTH OF RESPONSE WITH INCREASED FOLLOW-UP FOR PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH BRUTON’S TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB

EHA Library, Judith Trotman, 215493

CHARACTERIZATION OF MALT LYMPHOMA WITH T(11;18): LONG-TERM FOLLOW-UP

EHA Library, Kosuke Toyoda, 215494

CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): DESCRIPTION OF MAIN DISEASE FEATURES, CLINICAL COURSE AND OUTCOME IN A SERIES OF 98 CASES.

EHA Library, Christina Kalpadakis, 215495

OVERALL SURVIVAL OF MANTLE CELL LYMPHOMA (MCL) PATIENTS HAS BEEN SIGNIFICANTLY IMPROVED DURING THE TIME, MAINLY DUE TO THE RITUXIMAB MAINTENANCE IN ELDERLY POPULATION, REAL WORLD DATA.

EHA Library, Marek Trneny, 215496

IBRUTINIB FOR THE TREATMENT OF BING-NEEL SYNDROME

EHA Library, Jorge Castillo, 215497

IBRUTINIB MONOTHERAPY IN SYMPTOMATIC, TREATMENT-NAIVE PATIENTS WITH WALDENSTROM’S MACROGLOBULINEMIA.

EHA Library, Steven Treon, 215498

CLINICAL OUTCOME OF PATIENTS WITH LOCALIZED PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA (OAL): LONG-TERM FOLLOW-UP RESULTS FROM A SINGLE-INSTITUTION OBSERVATIONAL STUDY.

EHA Library, Ritsuko Nakai, 215499

CD5-NEGATIVE MANTLE CELL LYMPHOMA: A DIAGNOSTIC CHALLENGE IN LEUKEMIC NON-NODAL CASES EXCLUSIVELY DIAGNOSED IN PERIPHERAL BLOOD

EHA Library, Sara Montesdeoca Romero, 215500

MARGINAL-ZONE LYMPHOMA WITH AND WITHOUT ASSOCIATION OF HEPATITIS C VIRUS INFECTION: CLINICAL CORRELATION AND TREATMENT RESULTS

EHA Library, Gayane Tumyan, 215501

STUDY OF THE DISSEMINATION PATTERNS AND CLONAL RELATIONSHIP IN DIFFERENT SITES IN MULTI-SITED MALT LYMPHOMAS. A SINGLE CENTRE ANALYSIS.

EHA Library, Maria Condom, 215502

GENETIC POLYMORPHISMS OF DC-SIGN AND L-FICOLIN ARE ASSOCIATED WITH INFECTIOUS COMPLICATIONS AFTER INDUCTION CHEMOTHERAPY: A VALIDATION STUDY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Ulf Schnetzke, 215503

ONE-YEAR SURVIVAL AMONG PATIENTS WITH HEMATOLOGICAL DISEASE ADMITTED TO THE INTENSIVE CARE UNIT: A NATIONWIDE COHORT STUDY

EHA Library, Peter Asdahl, 215505

PREVALENCE AND RISK FACTORS OF RESISTANT GRAM-NEGATIVE BACILLI COLONIZATION AND INFECTION IN HOSPITALIZED HAEMATOLOGICAL PATIENTS

EHA Library, ANA PILAR GONZALEZ RODRIGUEZ, 215506

PEDIATRIC INTENSIVE CARE ADMISSIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Menie Rompola, 215507

OUTCOME OF HIGH RISK FEBRILE NEUTROPENIC PATIENTS WITH GUT COLONIZATION WITH CARBAPENEM RESISTANT ENTEROBACTERIACEAE(CRE) IN SURVEILLANCE CULTURES "

EHA Library, Sweta Lunkad, 215508

COLONIZATION WITH MULTIDRUG-RESISTANT BACTERIA (MDRB) IS ASSOCIATED WITH COMPLICATIONS AND POOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

EHA Library, Chiara Maria DELLACASA, 215509

ANTIBIOTICS CAN SAFELY BE DISCONTINUED IN NEUTROPENIC HEMATOLOGY PATIENTS: A PROSPECTIVE COHORT

EHA Library, Zoe Van de Wyngaert, 215510

RISK OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE ERA OF NOVEL THERAPIES: A RETROSPECTIVE SINGLE INSTITUTION EXPERIENCE

EHA Library, Francesco Autore, 215511